[Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)]

Internist (Berl). 2008 Apr;49(4):502-4. doi: 10.1007/s00108-008-2067-2.
[Article in German]
No abstract available

MeSH terms

  • Aged
  • Bone Density / drug effects
  • Bone Density Conservation Agents / administration & dosage*
  • Bone Density Conservation Agents / adverse effects
  • Diphosphonates / administration & dosage*
  • Diphosphonates / adverse effects
  • Drug Administration Schedule
  • Female
  • Fractures, Spontaneous / prevention & control*
  • Humans
  • Imidazoles / administration & dosage*
  • Imidazoles / adverse effects
  • Infusions, Intravenous
  • Male
  • Osteoporosis / drug therapy*
  • Randomized Controlled Trials as Topic
  • Secondary Prevention
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid